GSK to Sell Haleon Shares Worth Around $1.27 Billion
17 1월 2024 - 2:19AM
Dow Jones News
By Joe Hoppe
GSK said it will sell a stake in Haleon worth around 1.0 billion
pounds ($1.27 billion), reducing its stake in the
consumer-healthcare business to around 3.2%.
The British pharmaceutical giant said Tuesday that it will sell
around 300 million Haleon shares, with an offer price determined
through an accelerated bookbuild process starting immediately.
Haleon shares closed Tuesday at 333.6 pence.
U.S. pharma giant Pfizer also holds a 32% stake in Haleon, which
was spun out of GSK and Pfizer's consumer-healthcare business.
Write to Joe Hoppe at joseph.hoppe@wsj.com
(END) Dow Jones Newswires
January 16, 2024 12:04 ET (17:04 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
GSK (NYSE:GSK)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024
GSK (NYSE:GSK)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024
